Gossamer Bio (GOSS) Announces Clinical Trial Collaboration Agreement With Merck to Evaluate GB1275 in Combination With KEYTRUDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. BLZE
7. IBM
8. NKE
9. MU
10. ACN

Go back to Gossamer Bio (GOSS) Announces Clinical Trial Collaboration Agreement With Merck to Evaluate GB1275 in Combination With KEYTRUDA
Goss & De Leeuw Mach Co (NASDAQ: GOSS) Delayed: 0.17 +0.01 (6.25%)
Previous Close $0.16    52 Week High $0.00 
Open $0.16    52 Week Low $0.00 
Day High $0.18    P/E N/A 
Day Low $0.16    EPS $0.00 
Volume 13,383,427       

Merck & Co. (NYSE: MRK) Delayed: 119.60 +4.12 (3.57%)
Previous Close $115.48    52 Week High $65.46 
Open $116.53    52 Week Low $47.97 
Day High $119.80    P/E 81.36 
Day Low $116.53    EPS $1.47 
Volume 11,893,949